Heathcote EJ - Search Results

1

HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis.

Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, Miskovsky E, Shaffer E, Rulyak SJ, Kowdley KV. Nelson JE, et al. Among authors: heathcote ej. Hepatology. 2007 Sep;46(3):723-9. doi: 10.1002/hep.21742. Hepatology. 2007. PMID: 17680648

2

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.

Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, Colin P. Lindor KD, et al. Among authors: heathcote ej. Hepatology. 2004 Mar;39(3):770-8. doi: 10.1002/hep.20092. Hepatology. 2004. PMID: 14999696 Clinical Trial.

3

Primary biliary cirrhosis.

Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ; American Association for Study of Liver Diseases. Lindor KD, et al. Among authors: heathcote ej. Hepatology. 2009 Jul;50(1):291-308. doi: 10.1002/hep.22906. Hepatology. 2009. PMID: 19554543 Free article. No abstract available.

4

Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA)-positive and AMA-negative primary biliary cirrhosis.

Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcote EJ. Stone J, et al. Among authors: heathcote ej. J Hepatol. 2002 Jan;36(1):8-13. doi: 10.1016/s0168-8278(01)00237-9. J Hepatol. 2002. PMID: 11804658

5

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.

Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ. Joshi S, et al. Among authors: heathcote ej. Hepatology. 2002 Feb;35(2):409-13. doi: 10.1053/jhep.2002.30902. Hepatology. 2002. PMID: 11826416 Clinical Trial.

6

Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis.

Bonnand AM, Heathcote EJ, Lindor KD, Poupon RE. Bonnand AM, et al. Among authors: heathcote ej. Hepatology. 1999 Jan;29(1):39-43. doi: 10.1002/hep.510290140. Hepatology. 1999. PMID: 9862847 Clinical Trial.

7

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.

Poupon RE, Lindor KD, Parés A, Chazouillères O, Poupon R, Heathcote EJ. Poupon RE, et al. Among authors: heathcote ej. J Hepatol. 2003 Jul;39(1):12-6. doi: 10.1016/s0168-8278(03)00192-2. J Hepatol. 2003. PMID: 12821038 Clinical Trial.

8

Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?

Joshi S, Cauch-Dudek K, Heathcote EJ, Lindor K, Jorgensen R, Klein R. Joshi S, et al. Among authors: heathcote ej. Am J Gastroenterol. 2002 Apr;97(4):999-1002. doi: 10.1111/j.1572-0241.2002.05620.x. Am J Gastroenterol. 2002. PMID: 12003438

9

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.

Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Poupon RE, et al. Among authors: heathcote ej. Gastroenterology. 1997 Sep;113(3):884-90. doi: 10.1016/s0016-5085(97)70183-5. Gastroenterology. 1997. PMID: 9287980

10

Ursodeoxycholic acid for primary biliary cirrhosis.

Lindor KD, Poupon R, Poupon R, Heathcote EJ, Therneau T. Lindor KD, et al. Among authors: heathcote ej. Lancet. 2000 Feb 19;355(9204):657-8. doi: 10.1016/S0140-6736(05)72401-6. Lancet. 2000. PMID: 10697011 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page